New Cervical Cancer Treatment Cuts Death Risk by 40%, Experts Call for NHS Rollout

Oct 15, 2024, 06:32 AM

Researchers have discovered that a simple change in the administration order of drugs for cervical cancer treatment can reduce the risk of death by 40%. This breakthrough, described as the biggest in two decades, has led experts to call for a full NHS rollout. The new regime, which has been supported by a study published in The Lancet, has the potential to transform survival rates for patients with cervical cancer.